UK markets open in 9 minutes
  • NIKKEI 225

    27,970.22
    +136.93 (+0.49%)
     
  • HANG SENG

    25,443.21
    -749.11 (-2.86%)
     
  • CRUDE OIL

    71.95
    +0.04 (+0.06%)
     
  • GOLD FUTURES

    1,794.00
    -5.20 (-0.29%)
     
  • DOW

    35,144.31
    +82.76 (+0.24%)
     
  • BTC-GBP

    26,885.56
    -1,353.46 (-4.79%)
     
  • CMC Crypto 200

    879.66
    -35.83 (-3.91%)
     
  • ^IXIC

    14,840.71
    +3.72 (+0.03%)
     
  • ^FTAS

    4,025.99
    +0.87 (+0.02%)
     

Global Nerve Repair and Regeneration Devices Market to Reach $11.8 Billion by 2026

·24-min read

Abstract: Global Nerve Repair and Regeneration Devices Market to Reach $11. 8 Billion by 2026 . - Nerve repair and regeneration products are used for restoration of the normal functioning of damaged nerves.

New York, June 23, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Nerve Repair and Regeneration Devices Industry" - https://www.reportlinker.com/p05957490/?utm_source=GNW
The rapid rise in the incidence of nerve injuries worldwide, increasing prevalence of various neurological disorders, especially in the expanding elderly population, and development of advanced technology-based nerve repair and regeneration products are fueling growth in the global market. The constant increase in incidence of nerve injuries is leading to high demand for nerve repair and regeneration products. The growing incidence of chronic nervous system disorders such as Parkinson`s and Alzheimer`s disease is also driving demand for nerve repair and regeneration procedures and devices. There is also increased funding for clinical trials aimed at development of effective and safe therapies for treatment of various neurological disorders. Initiatives such as stem cells in umbilical blood infusion for cerebral palsy; and the use of Polyethylene glycol (PEG) drug for promoting axonal fusion technique for repairing peripheral nerve injuries are favoring market growth.

- Amid the COVID-19 crisis, the global market for Nerve Repair and Regeneration Devices estimated at US$6.6 Billion in the year 2020, is projected to reach a revised size of US$11.8 Billion by 2026, growing at a CAGR of 10% over the analysis period. Neurostimulation & Neuromodulation Devices, one of the segments analyzed in the report, is projected to grow at a 9.7% CAGR to reach US$10.9 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Biomaterials segment is readjusted to a revised 11.7% CAGR for the next 7-year period. This segment currently accounts for a 13.8% share of the global Nerve Repair and Regeneration Devices market. The neurostimulation and neuromodulation devices segment growth will be fueled by rising incidence of peripheral nerve injuries, development of technologically advanced products and favorable reimbursement scenario. Within the segment, internal neurostimulation and neuromodulation devices category is being driven due to the devices` ability to lower occurrence of post-surgical complications and reducing duration of hospitalization. Biomaterials segment is expected to witness high growth, driven by broadening application range, increased availability of government funding for innovations, and development of advanced products.

The U.S. Market is Estimated at $2.2 Billion in 2021, While China is Forecast to Reach $1.8 Billion by 2026

- The Nerve Repair and Regeneration Devices market in the U.S. is estimated at US$2.2 Billion in the year 2021. The country currently accounts for a 30.45% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$1.8 Billion in the year 2026 trailing a CAGR of 13% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.7% and 8.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.2% CAGR while Rest of European market (as defined in the study) will reach US$2 Billion by the end of the analysis period. Increasing incidence of neurological diseases and expanding geriatric population, increasing spending on healthcare sector, positive reimbursement framework and presence of several leading industry players are fueling growth in the North America region. Asia-Pacific is poised to grow at a robust pace, driven by sizeable patient pool, favorable healthcare initiatives and high unmet healthcare needs. The Asia-Pacific market is expected to gain from notable surge in aging population, increasing awareness regarding neurological disorders, and rising incidence of cancer and osteoporosis.
Select Competitors (Total 61 Featured)

  • ABB Ltd.

  • Accuenergy Ltd.

  • Albireo Energy, LLC

  • Eaton Corporation Inc.

  • Emerson Electric Company

  • Fluke Corporation

  • Fuji Electric FA Components & Systems Co., Ltd.

  • GE Grid Solutions

  • Greystone Energy Systems Inc.

  • Littelfuse, Inc.

  • Mitsubishi Electric Corporation

  • Omron Corporation

  • Rockwell Automation, Inc.

  • Samsara Networks, Inc.

  • Schneider Electric SE

  • Siemens AG

  • VaCom Technologies

  • Veris Industries

  • Yokogawa Electric Corporation.




Read the full report: https://www.reportlinker.com/p05957490/?utm_source=GNW

CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual
% Change) for 2019 to 2022
Global Nerve Repair & Regeneration Market Buckles under COVID-
19 Strain
Covid-19 Patients in Prone Position Suffering Nerve Damage
Bodes Well for Market Growth
Nerve Repair and Regeneration Market Set for a Robust Growth
Neurostimulation & Neuromodulation Devices Hold Commanding Slot
in Nerve Repair & Regeneration Market
Biomaterials to Exhibit Rapid Growth
Nerve Repair and Regeneration Market by Application
US and Europe Dominate the Market
Asia-Pacific and other Emerging Regions Display Impressive
Growth Potential
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
High Incidence of Neurological Disorders: A Key Market Driver
EXHIBIT 2: Annual Incidence of Adult-Onset Neurologic Disorders
in the US
Effects of COVID-19 on the Nervous System Sheds Focus on
Neuromodulation Applications
Increasing Cases of Peripheral Nerve Injuries Drive the Nerve
Repair and Regeneration Market
Growing Number of Vehicular Accidents Drive the Peripheral
Nerve injuries Repair Market
Rising Geriatric Population and Subsequent Growth in Prevalence
of Neurological Disorders
EXHIBIT 3: Global Population Statistics for the 65+ Age Group
in Million by Geographic Region for the Years 2019, 2025, 2035
and 2050
Growing Incidence of Neurodegenerative Diseases Propels the
Market for Deep Brain Stimulation Devices
EXHIBIT 4: Global Alzheimer’s Prevalence by Age Group
EXHIBIT 5: Diagnosed Prevalence Cases of Parkinson?s Disease
Across Select Countries
EXHIBIT 6: Global DBS Market by Leading Player (2020E): Market
Share Breakdown of Revenues for Medtronic, Boston Scientific,
and Abbott
Select Available Deep Brain Stimulation Devices Available in
the Market
Intensified Research Activity Across Various Neural Disciplines
Induces Additional Optimism
Stem Cell Therapy: A Promising Avenue for Nerve Repair and
Regeneration
Increasing Cases of Epilepsy Drives the Demand for Vagus Nerve
Stimulation Devices
EXHIBIT 7: Epilepsy Incidence by Type (2019): Percentage Share
Breakdown for Idiopathic and Symptomatic Epilepsy
EXHIBIT 8: Symptomatic Epilepsy Incidence by Type (2019):
Percentage Share Breakdown of Congenital, Degenerative,
Infective, Neoplastic, Trauma, and Vascular Epilepsy
Spinal Cord Injuries Propel the Demand for Spinal Cord
Stimulation Devices
Recent Developments in Spinal Cord Injury Treatment
Biomaterials (Nerve Conduits and Nerve Wraps) to Witness Rapid
Growth
New Biomaterials Pave the Way for Innovative Neurodegeneration
Therapies
Role of Nerve Conduits in the Treatment of Peripheral Nerve Injury
Innovative Nerve Conduits from Stryker
TENS (Transcutaneous electrical nerve stimulation devices)
Market Witnesses Rapid Growth
Non-Invasiveness of TMS (Transcranial Magnetic Stimulation)
Propelling the adoption of TMS devices
Nerve Grafts for Bridging Larger Nerve Gaps
Role of Nerve Grafting in Treatment of Peripheral Nerve Injuries
FDA-approved Nerve Tubes for Peripheral Nerve Repair

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Nerve Repair and
Regeneration Devices by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Nerve Repair and
Regeneration Devices by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Nerve Repair and
Regeneration Devices by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Neurostimulation &
Neuromodulation Devices by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Neurostimulation &
Neuromodulation Devices by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Neurostimulation &
Neuromodulation Devices by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 7: World Current & Future Analysis for Biomaterials by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Biomaterials by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Biomaterials by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Neurostimulation &
Neuromodulation Surgeries by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Neurostimulation &
Neuromodulation Surgeries by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Neurostimulation &
Neuromodulation Surgeries by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 13: World Current & Future Analysis for Neurorrhaphy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for Neurorrhaphy by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Neurorrhaphy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Nerve Grafting by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 17: World Historic Review for Nerve Grafting by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Nerve Grafting by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Stem Cell Therapy
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 20: World Historic Review for Stem Cell Therapy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Stem Cell Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Hospitals &
Clinics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Hospitals & Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Hospitals & Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Ambulatory
Surgery Centers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Ambulatory Surgery Centers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Ambulatory Surgery
Centers by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

III. MARKET ANALYSIS

UNITED STATES
Table 28: USA Current & Future Analysis for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 29: USA Historic Review for Nerve Repair and Regeneration
Devices by Product - Neurostimulation & Neuromodulation Devices
and Biomaterials Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 30: USA 15-Year Perspective for Nerve Repair and
Regeneration Devices by Product - Percentage Breakdown of Value
Sales for Neurostimulation & Neuromodulation Devices and
Biomaterials for the Years 2012, 2020 & 2027

Table 31: USA Current & Future Analysis for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 32: USA Historic Review for Nerve Repair and Regeneration
Devices by Application - Neurostimulation & Neuromodulation
Surgeries, Neurorrhaphy, Nerve Grafting and Stem Cell Therapy
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 33: USA 15-Year Perspective for Nerve Repair and
Regeneration Devices by Application - Percentage Breakdown of
Value Sales for Neurostimulation & Neuromodulation Surgeries,
Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for the
Years 2012, 2020 & 2027

Table 34: USA Current & Future Analysis for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 35: USA Historic Review for Nerve Repair and Regeneration
Devices by End-Use - Hospitals & Clinics and Ambulatory Surgery
Centers Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 36: USA 15-Year Perspective for Nerve Repair and
Regeneration Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Clinics and Ambulatory Surgery Centers
for the Years 2012, 2020 & 2027

CANADA
Table 37: Canada Current & Future Analysis for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 38: Canada Historic Review for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 39: Canada 15-Year Perspective for Nerve Repair and
Regeneration Devices by Product - Percentage Breakdown of Value
Sales for Neurostimulation & Neuromodulation Devices and
Biomaterials for the Years 2012, 2020 & 2027

Table 40: Canada Current & Future Analysis for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 41: Canada Historic Review for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 42: Canada 15-Year Perspective for Nerve Repair and
Regeneration Devices by Application - Percentage Breakdown of
Value Sales for Neurostimulation & Neuromodulation Surgeries,
Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for the
Years 2012, 2020 & 2027

Table 43: Canada Current & Future Analysis for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 44: Canada Historic Review for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 45: Canada 15-Year Perspective for Nerve Repair and
Regeneration Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Clinics and Ambulatory Surgery Centers
for the Years 2012, 2020 & 2027

JAPAN
Table 46: Japan Current & Future Analysis for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 47: Japan Historic Review for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 48: Japan 15-Year Perspective for Nerve Repair and
Regeneration Devices by Product - Percentage Breakdown of Value
Sales for Neurostimulation & Neuromodulation Devices and
Biomaterials for the Years 2012, 2020 & 2027

Table 49: Japan Current & Future Analysis for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 50: Japan Historic Review for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 51: Japan 15-Year Perspective for Nerve Repair and
Regeneration Devices by Application - Percentage Breakdown of
Value Sales for Neurostimulation & Neuromodulation Surgeries,
Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for the
Years 2012, 2020 & 2027

Table 52: Japan Current & Future Analysis for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 53: Japan Historic Review for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 54: Japan 15-Year Perspective for Nerve Repair and
Regeneration Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Clinics and Ambulatory Surgery Centers
for the Years 2012, 2020 & 2027

CHINA
Table 55: China Current & Future Analysis for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 56: China Historic Review for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 57: China 15-Year Perspective for Nerve Repair and
Regeneration Devices by Product - Percentage Breakdown of Value
Sales for Neurostimulation & Neuromodulation Devices and
Biomaterials for the Years 2012, 2020 & 2027

Table 58: China Current & Future Analysis for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 59: China Historic Review for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 60: China 15-Year Perspective for Nerve Repair and
Regeneration Devices by Application - Percentage Breakdown of
Value Sales for Neurostimulation & Neuromodulation Surgeries,
Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for the
Years 2012, 2020 & 2027

Table 61: China Current & Future Analysis for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 62: China Historic Review for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 63: China 15-Year Perspective for Nerve Repair and
Regeneration Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Clinics and Ambulatory Surgery Centers
for the Years 2012, 2020 & 2027

EUROPE
Table 64: Europe Current & Future Analysis for Nerve Repair and
Regeneration Devices by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 65: Europe Historic Review for Nerve Repair and
Regeneration Devices by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 66: Europe 15-Year Perspective for Nerve Repair and
Regeneration Devices by Geographic Region - Percentage
Breakdown of Value Sales for France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets for Years 2012, 2020 & 2027

Table 67: Europe Current & Future Analysis for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 68: Europe Historic Review for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 69: Europe 15-Year Perspective for Nerve Repair and
Regeneration Devices by Product - Percentage Breakdown of Value
Sales for Neurostimulation & Neuromodulation Devices and
Biomaterials for the Years 2012, 2020 & 2027

Table 70: Europe Current & Future Analysis for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 71: Europe Historic Review for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 72: Europe 15-Year Perspective for Nerve Repair and
Regeneration Devices by Application - Percentage Breakdown of
Value Sales for Neurostimulation & Neuromodulation Surgeries,
Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for the
Years 2012, 2020 & 2027

Table 73: Europe Current & Future Analysis for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 74: Europe Historic Review for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 75: Europe 15-Year Perspective for Nerve Repair and
Regeneration Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Clinics and Ambulatory Surgery Centers
for the Years 2012, 2020 & 2027

FRANCE
Table 76: France Current & Future Analysis for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 77: France Historic Review for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 78: France 15-Year Perspective for Nerve Repair and
Regeneration Devices by Product - Percentage Breakdown of Value
Sales for Neurostimulation & Neuromodulation Devices and
Biomaterials for the Years 2012, 2020 & 2027

Table 79: France Current & Future Analysis for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 80: France Historic Review for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 81: France 15-Year Perspective for Nerve Repair and
Regeneration Devices by Application - Percentage Breakdown of
Value Sales for Neurostimulation & Neuromodulation Surgeries,
Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for the
Years 2012, 2020 & 2027

Table 82: France Current & Future Analysis for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 83: France Historic Review for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 84: France 15-Year Perspective for Nerve Repair and
Regeneration Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Clinics and Ambulatory Surgery Centers
for the Years 2012, 2020 & 2027

GERMANY
Table 85: Germany Current & Future Analysis for Nerve Repair
and Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 86: Germany Historic Review for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 87: Germany 15-Year Perspective for Nerve Repair and
Regeneration Devices by Product - Percentage Breakdown of Value
Sales for Neurostimulation & Neuromodulation Devices and
Biomaterials for the Years 2012, 2020 & 2027

Table 88: Germany Current & Future Analysis for Nerve Repair
and Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 89: Germany Historic Review for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 90: Germany 15-Year Perspective for Nerve Repair and
Regeneration Devices by Application - Percentage Breakdown of
Value Sales for Neurostimulation & Neuromodulation Surgeries,
Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for the
Years 2012, 2020 & 2027

Table 91: Germany Current & Future Analysis for Nerve Repair
and Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 92: Germany Historic Review for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 93: Germany 15-Year Perspective for Nerve Repair and
Regeneration Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Clinics and Ambulatory Surgery Centers
for the Years 2012, 2020 & 2027

ITALY
Table 94: Italy Current & Future Analysis for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 95: Italy Historic Review for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 96: Italy 15-Year Perspective for Nerve Repair and
Regeneration Devices by Product - Percentage Breakdown of Value
Sales for Neurostimulation & Neuromodulation Devices and
Biomaterials for the Years 2012, 2020 & 2027

Table 97: Italy Current & Future Analysis for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve G
Read the full report: https://www.reportlinker.com/p05957490/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting